-
September 19, 2022 End of Life: Psychedelics in Palliative CareWe interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics...
-
September 13, 2022 Psychedelic South: The Quest to find Good Drugs in AlabamaMoving from San Francisco to Alabama comes with some culture shock, including the inability to...
-
September 6, 2022 Finding the Messy Middle with Sex and PsychedelicsCombining sex and psychedelics can be fun and adventurous, but it can also be confusing...
-
August 9, 2022 Psychedelic Clinical Trials and the Michael Pollan EffectWith the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on...
-
August 8, 2022 Three Phase 3 Clinical Trials that Could Legalize PsychedelicsThe road to psychedelic legalization has many paths. These 3 clinical trials have the best...
-
July 21, 2022 Opiate Addiction: Jails, Institutions, Death… and PsychedelicsPsychedelics have the potential to treat the suffering caused by opiate addiction, but treatment is...
-
June 29, 2022 Medical Applications of Ketamine & Common Misconceptions with Christi Myers, Flow IntegrativeIn this episode, Christi provides insight into how ketamine impacts people's physical and mental health....
-
June 15, 2022 Examining Ketamine Therapy with Myriam Barthes, Journey ClinicalIn today’s episode, Myriam describes the impact of ketamine on the mind and the body,...
-
June 3, 2022 Psychedelic Business Spotlight – June 3This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on...
-
May 13, 2022 Psychedelic Business Spotlight – May 13This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the...
